Influence of the semisynthetic bile acid MKC on the ileal permeation of gliclazide in vitro in healthy and diabetic rats treated with probiotics
The aim of this study was to investigate the influence of sodium 3a,7a-dihydroxy-12-keto-5ß-cholanate (MKC) on the ileal permeation of gliclazide in healthy and diabetic rats treated with probiotics. Male Wistar rats (2-3 months, 350 ± 50 g) were randomly allocated into four groups (n = 32); Groups...
| Main Authors: | Al-Salami, Hani, Butt, G., Tucker, I., Mikov, M. |
|---|---|
| Format: | Journal Article |
| Published: |
2008
|
| Online Access: | http://hdl.handle.net/20.500.11937/24675 |
Similar Items
Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)
by: Al-Salami, Hani, et al.
Published: (2009)
THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS
by: Mikov, M., et al.
Published: (2014)
by: Mikov, M., et al.
Published: (2014)
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012)
by: Al-Salami, Hani, et al.
Published: (2012)
Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
by: Al-Salami, Hani, et al.
Published: (2008)
by: Al-Salami, Hani, et al.
Published: (2008)
Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)
by: Mikov, M., et al.
Published: (2017)
Bile acids and probiotics could help treating diabetes
by: Calasan, J., et al.
Published: (2012)
by: Calasan, J., et al.
Published: (2012)
Deoxycholic Acid as a Modifier of the Permeation of Gliclazide through the Blood Brain Barrier of a Rat
by: Lalic-Popovic, M., et al.
Published: (2013)
by: Lalic-Popovic, M., et al.
Published: (2013)
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes
by: Mathavan, Sangeetha, et al.
Published: (2015)
by: Mathavan, Sangeetha, et al.
Published: (2015)
High-Loading Dose of Microencapsulated Gliclazide Formulation Exerted a Hypoglycaemic Effect on Type 1 Diabetic Rats and Incorporation of a Primary Deconjugated Bile Acid, Diminished the Hypoglycaemic Antidiabetic Effect
by: Golocorbin-Kon, S., et al.
Published: (2017)
by: Golocorbin-Kon, S., et al.
Published: (2017)
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
Morphological, Stability, and Hypoglycemic Effects of New Gliclazide-Bile Acid Microcapsules for Type 1 Diabetes Treatment: the Microencapsulation of Anti-diabetics Using a Microcapsule-Stabilizing Bile Acid
by: Mathavan, S., et al.
Published: (2018)
by: Mathavan, S., et al.
Published: (2018)
The applications of microencapsulated formulation of gliclazide and bile acids in Type-1 diabetes mellitus
by: Mathavan, Sangeetha
Published: (2017)
by: Mathavan, Sangeetha
Published: (2017)
Pharmacokinetic and Drug Absorption Profiles of the Anti-Hyperglycaemic Agent Gliclazide in Oral Tissue-Targeted Microcapsules in Rats
by: Jovic, Jelena, et al.
Published: (2020)
by: Jovic, Jelena, et al.
Published: (2020)
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014)
by: Mooranian, Armin, et al.
Published: (2014)
Synthesis and Characterization of Semisynthetic Metallothermolysin
by: Khalid, Syarajatul Erma
Published: (2008)
by: Khalid, Syarajatul Erma
Published: (2008)
The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus
by: Woodhams, L., et al.
Published: (2017)
by: Woodhams, L., et al.
Published: (2017)
The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes
by: Mathavan, S., et al.
Published: (2015)
by: Mathavan, S., et al.
Published: (2015)
Correlation between in vitro tests for blood brain barrier penetration with in vivo gliclazide penetration
by: Lalic-Popovic, M., et al.
Published: (2013)
by: Lalic-Popovic, M., et al.
Published: (2013)
Probiotics applications in autoimmune diseases
by: Al-Salami, Hani, et al.
Published: (2012)
by: Al-Salami, Hani, et al.
Published: (2012)
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
by: Danic, M., et al.
Published: (2018)
by: Danic, M., et al.
Published: (2018)
Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles
by: Pavlovic, N., et al.
Published: (2018)
by: Pavlovic, N., et al.
Published: (2018)
Protein Structure-Based Design of Novel Semisynthetic Metallotrypsin
by: Misran, Azizah
Published: (2006)
by: Misran, Azizah
Published: (2006)
Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects
by: Mathavan, S., et al.
Published: (2017)
by: Mathavan, S., et al.
Published: (2017)
The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs
by: Stojancevic, M., et al.
Published: (2013)
by: Stojancevic, M., et al.
Published: (2013)
Decreased placental and transcellular permeation of cefuroxime in pregnant women with diabetes
by: Lalic-Popovic, M., et al.
Published: (2015)
by: Lalic-Popovic, M., et al.
Published: (2015)
The Effect of Diabetes and Hypertension on the Placental Permeation of the Hydrophilic Drug, Ranitidine
by: Lalic-Popovic, M., et al.
Published: (2016)
by: Lalic-Popovic, M., et al.
Published: (2016)
Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid
by: Mooranian, A., et al.
Published: (2018)
by: Mooranian, A., et al.
Published: (2018)
Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)
by: Stojancevic, M., et al.
Published: (2014)
Diabetes and hypertension increase the placental and transcellular permeation of the lipophilic drug diazepam in pregnant women
by: Lalic-Popovic, M., et al.
Published: (2013)
by: Lalic-Popovic, M., et al.
Published: (2013)
Survival of Isolated Probiotic Yeast Strains from Kefir Towards Bile and Acidic Environments
by: Azhar, M. A., et al.
Published: (2023)
by: Azhar, M. A., et al.
Published: (2023)
Development and validation of a new analytical HPLC method for simultaneous determination of the antidiabetic drugs, metformin and gliclazide
by: Gedawy, A., et al.
Published: (2018)
by: Gedawy, A., et al.
Published: (2018)
The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes
by: Mooranian, Armin, et al.
Published: (2016)
by: Mooranian, Armin, et al.
Published: (2016)
Bile salt deconjugation and cholesterol removal from media by Lactobacillus strains used as probiotics in chickens
by: Ramasamy, Kalavathy, et al.
Published: (2010)
by: Ramasamy, Kalavathy, et al.
Published: (2010)
Drug Permeation across the Blood-Brain Barrier: Applications of Nanotechnology
by: Fakhoury, M., et al.
Published: (2015)
by: Fakhoury, M., et al.
Published: (2015)
A Molecular Modelling Approach for Designing a Novel Semisynthetic Metalloenzyme Based on Thermolysin
by: Jaafar, Ahmad Haniff
Published: (2006)
by: Jaafar, Ahmad Haniff
Published: (2006)
The influence of bile salts on the distribution of simvastatin in the octanol/buffer system
by: Đanić, M., et al.
Published: (2016)
by: Đanić, M., et al.
Published: (2016)
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
by: Mooranian, Armin, et al.
Published: (2015)
by: Mooranian, Armin, et al.
Published: (2015)
Primary Bile Acid Chenodeoxycholic Acid-Based Microcapsules to Examine ß-cell Survival and the Inflammatory Response
by: Mooranian, A., et al.
Published: (2016)
by: Mooranian, A., et al.
Published: (2016)
In vivo study of the pharmacokinetic effect of amlodipine and gliclazide
by: Helal Uddin, A.B.M., et al.
Published: (2017)
by: Helal Uddin, A.B.M., et al.
Published: (2017)
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)
by: Mooranian, A., et al.
Published: (2015)
Similar Items
-
Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009) -
THE EFFECT OF BILE ACID SALT SODIUM 3ALPHA, 7ALPHA-DIHYDROXY-12-KETO-5BETA-CHOLANATE (MKC) AND PROBIOTIC PRETREATMENT ON GLICLAZIDE PERMEATION IN ILEAL TISSUES FROM HEALTHY AND DIABETIC RATS
by: Mikov, M., et al.
Published: (2014) -
Probiotics decreased the bioavailability of the bile acid analog, monoketocholic acid, when coadministered with gliclazide, in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2012) -
Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats
by: Al-Salami, Hani, et al.
Published: (2008) -
Potential Applications of Gliclazide in Treating Type 1 Diabetes Mellitus: Formulation with Bile Acids and Probiotics
by: Mikov, M., et al.
Published: (2017)